| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to eye drops that contain 1-3 wt % of taurine, 0.01-0.1 wt % of dexamethasone, 0.4-0.6 wt % of boric acid, 0.4-0.6 wt % of hydroxypropyl methyl cellulose and water. The eye drops aim at treating various eye diseases related to metabolic disturbance in eye tissues, and inflammatory injury of an eye surface.EFFECT: higher therapeutic efficacy of the eye drops.3 ex |
